WELAB BARCELONA
Scientific Services
At Welab Barcelona we have end-to-end technological capabilities, expertise, and in-depth knowledge of the key steps of the pharmaceutical R&D process and standards. We aim to be your partner in the Discovery and Development of new drugs or repurposing approaches for providing next generation therapies to patients.
Welab Barcelona platform offers drug discovery and development services along with know-how for supporting your drug R&D program, including gap identification, definition of the critical path, value proposition, and competitive differentiation.
WELAB BARCELONA
Drug discovery workflow
The research center has integrated capabilities spanning the entire drug discovery value chain, from target identification to pre-clinical development as well as clinical phase and regulatory support.
WELAB BARCELONA
Who we are
Welab Barcelona platform offers drup discovery and development services along with know-how for supporting your drug R&D program, including gap identification, definition of the critical path, value proposition, and competitive differentiation.
At our core, we are a dynamic and well-balanced team poised for excellence in the pharmaceutical industry. With an average of over 20 years of experience in the field, our board members bring a wealth of industry knowledge to the table.
Our team comprises a highly motivated group of scientists, ranging from early licensed professionals to senior collaborators. We foster a culture of innovation and dedication, driven by our passion for advancing pharmaceutical science.
WELAB BARCELONA
News

A new JMedChem publication from Welab
Discovery of WLB-89462, a New Drug-like and Highly Selective σ2 Receptor Ligand with Neuroprotective Properties”, in the Journal of Medicinal

Fundación MEDINA and WeLab Barcelona
Fundación Medina and WeLab Barcelona have signed a collaboration agreement that allows combining experience and resources for the discovery and

New Sigma-1 receptor-BiP biosensor
Scientists from the Pathology and Experimental Therapeutics Dept., Facultat de Medicina i Ciències de la Salut of the Universitat de
